Mark Ricciardi, MD, describes the ideal patients for TAVR and other minimally invasive procedures.
Related Presenters
Director of Interventional Cardiology and Structural Heart Disease, Clinical and Research Programs
Expertise in aortic (TAVR), mitral (TMVR, MitraClip), tricuspid commercial and investigational device therapies as well as complex coronary intervention (PCI) and chronic total occlusion (CTO) interventions.
Related Videos
